Search hospitals
>
Ohio
>
Dayton
CCOP - Dayton
Claim this profile
Dayton, Ohio 45429
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Pancreatic Cancer
Conducts research for Cancer
Conducts research for Lymphoma
235 reported clinical trials
1 medical researcher
Summary
CCOP - Dayton is a medical facility located in Dayton, Ohio. This center is recognized for care of Breast Cancer, Lung Cancer, Pancreatic Cancer, Cancer, Lymphoma and other specialties. CCOP - Dayton is involved with conducting 235 clinical trials across 438 conditions. There are 1 research doctors associated with this hospital, such as Howard M. Gross.
Area of expertise
Breast Cancer
CCOP - Dayton has run 78 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
CCOP - Dayton has run 62 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Clinical Trials running at CCOP - Dayton
Bladder Cancer
Lung Cancer
Breast Cancer
Prostate Cancer
Breast cancer
Esophageal cancer
Multiple Myeloma
Kidney Cancer
Colorectal Cancer
Melanoma
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting
2 awards
Phase 3
Gemcitabine + Docetaxel vs BCG
for Bladder Cancer
This trial is testing whether a combination of two drugs, Gemcitabine and Docetaxel, given directly into the bladder, is effective for patients with high-grade non-muscle invasive bladder cancer who have not been treated with the standard therapy before. The goal is to see if this new treatment can prevent cancer from coming back or spreading. The study will also look at the quality of life, safety, and side effects of the new treatment. Gemcitabine and Docetaxel have shown promise as an alternative treatment, especially in cases where the standard therapy fails or is not tolerated.
Recruiting
2 awards
Phase 3
14 criteria
Blood Sample Collection
for Cancer Detection
This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.
Recruiting
1 award
N/A
9 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at CCOP - Dayton?
CCOP - Dayton is a medical facility located in Dayton, Ohio. This center is recognized for care of Breast Cancer, Lung Cancer, Pancreatic Cancer, Cancer, Lymphoma and other specialties. CCOP - Dayton is involved with conducting 235 clinical trials across 438 conditions. There are 1 research doctors associated with this hospital, such as Howard M. Gross.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.